RVTYNYSELaboratory Analytical InstrumentsFiscal year ends December 29
REVVITY, INC.
Financials through Q2 FY2026, quarter ended Jul 5, 2026Last filing: 10-Q on Aug 11, 2026
$150.94−1.70 (-1.11%)
Close on Oct 19, 2026
- Market cap
- $16.85B
- P/E (TTM)
- 71.9
- Dividend yield
- 0.19%
REVVITY, INC. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostics [Member] | $370.99M | $349.27M | $390.07M | $356.13M | $354.39M | $324.37M | $354.61M | $345.25M | $343.16M | $313.41M | $210.36M | $362.88M | 50.8% | +4.7% |
| Life Sciences [Member] | $358.70M | $361.85M | $381.99M | $342.82M | $365.90M | $340.40M | $374.76M | $338.80M | $348.53M | $336.51M | $485.54M | $307.86M | 49.2% | -2.0% |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $603.41M | $581.46M | $647.00M | $573.23M | $610.70M | $562.68M | $620.28M | $580.00M | $589.09M | $548.84M | $612.48M | $586.68M | 82.7% | -1.2% |
| Service [Member] | $126.28M | $129.66M | $125.06M | $125.72M | $109.58M | $102.08M | $109.09M | $104.05M | $102.59M | $101.08M | $83.42M | $84.06M | 17.3% | +15.2% |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas [Member] | $325.58M | $315.99M | $320.48M | $307.28M | $323.58M | $304.63M | $318.63M | $302.33M | $307.78M | $294.35M | $301.16M | $293.60M | 44.6% | +0.6% |
| Europe [Member] | $229.04M | $223.05M | $237.16M | $202.40M | $203.63M | $181.79M | $197.43M | $182.04M | $184.59M | $178.56M | $192.45M | $178.06M | 31.4% | +12.5% |
| Asia [Member] | $175.06M | $172.08M | $214.42M | $189.28M | $193.07M | $178.34M | $213.32M | $199.69M | $199.31M | $177.00M | $202.29M | $199.09M | 24.0% | -9.3% |
From the segment and revenue-disaggregation notes of Revvity's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.